Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope

Frederik Dalgaard, Jannik L Pallisgaard, Anna-Karin Numé, Tommi Bo Lindhardt, Gunnar H Gislason, Christian Torp-Pedersen, Martin H Ruwald

Research output: Contribution to journalConference article in JournalResearchpeer-review

5 Citations (Scopus)

Abstract

OBJECTIVES: Management of atrial fibrillation (AF) with rate and/or rhythm control could lead to fall-related injuries and syncope, especially in the older AF population. We aimed to determine the association of rate and/or rhythm control with fall-related injuries and syncope in a real-world older AF cohort.

DESIGN: A retrospective cohort study.

SETTING: Danish nationwide administrative registries from 2000 to 2015.

PARTICIPANTS: A total of 100 935 patients with AF aged 65 years or older claiming prescription of rate-lowering drugs (RLDs) and/or anti-arrhythmic drugs (AADs) were included. We compared the use of rate-lowering monotherapy with rate-lowering dual therapy, AAD monotherapy, and AAD combined with rate-lowering therapy.

MEASUREMENTS: Outcomes were fall-related injuries and syncope as a composite end point (primary) or separate end point (secondary).

RESULTS: In this population, the median age was 78 years (interquartile range [IQR] = 72-84 y), and 53 481 (53.0%) were women. During a median follow-up of 2.1 years (IQR = 1.0-5.1), 17 132 (17.0%) experienced a fall-related injury, 5745 (5.7%) had a syncope, and 21 093 (20.9%) experienced either. Compared with rate-lowering monotherapy, AADs were associated with a higher risk of fall-related injuries and syncope. The incidence rate ratio (IRR) for the composite end point was 1.29 (95% confidence interval [CI]: 1.17-1.43) for AAD monotherapy and 1.46 [95% CI = 1.34-1.58] for AAD combined with rate-lowering therapy. When stratifying by individual drugs, amiodarone significantly increased the risk of fall-related injuries and syncope (IRR = 1.40 [1.26-1.55]). Compared with more than 180 days of rate-lowering monotherapy, a higher risk of all outcomes was seen in the first 90 days of any treatment; however, the greatest risk was in the first 14 days for those treated with AADs.

CONCLUSION: In AF patients aged 65 years and older, AAD use was associated with a higher risk of fall-related injuries and syncope, and the risk was highest within the first 14 days for those treated with AADs. Only amiodarone use was associated with a higher risk.

Original languageEnglish
JournalJournal of the American Geriatrics Society
Volume67
Issue number10
Pages (from-to)2023-2030
Number of pages8
ISSN0002-8614
DOIs
Publication statusPublished - Oct 2019
EventEuropean Society of Cardiology Congress 2018 - München, Germany
Duration: 25 Aug 201829 Aug 2018

Conference

ConferenceEuropean Society of Cardiology Congress 2018
CountryGermany
CityMünchen
Period25/08/201829/08/2018

Keywords

  • anti-arrhythmic drugs
  • atrial fibrillation
  • fall-related injury
  • rate-lowering drugs
  • syncope

Fingerprint Dive into the research topics of 'Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope'. Together they form a unique fingerprint.

Cite this